As a trend, new products have helped some companies achieve higher prices while the market for hip and knee replacements has slowed because patients may be postponing surgery, as the surgeries require high out-of pocket costs and long recoveries.
Additionally, some of the market’s difficulties can be attributed to a weakened euro.
Read The Wall Street Journal report on orthopedic device manufacturers’ reports.
Read other coverage on fiscal year results.
-Biomet Announces 4Q FY 2010 Financial Results
-Medtronic Posts FY 2010 Revenue of $15.8B
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.